For those that might be interested: As of yesterday, Sweden's 7day new death moving average continues to hover around 1, and has been very low for weeks. In a nation of over 10 million, they have "71,961 Currently Infected Patients, 71,935 (100%) in Mild Condition and 26 (0%) in Serious or Critical". (apparently rounding on the % ) I had previously expressed curiosity about
whether, in addition to shooting for herd immunity, they were using much hydroxychloroquine(HCQ), as the Swiss have been? I have also said I had read that the supplement Quercetin works as a zinc ionophore, in the same way that hydroxychloroquine does. Then I saw this today:https://swprs.org/on-the-treatment-of-covid-19/
" From Swiss Policy Research
On the treatment of Covid-19
Published: July 2, 2020; Updated: August 20, 2020
Languages: DE, EN; Share on: Twitter / Facebook
Immunological and serological studies show that most people develop no symptoms or only mild symptoms when infected with the new coronavirus, while some people may experience a more pronounced or critical course of the disease.
Based on the available scientific evidence and current clinical experience, the SPR Collaboration recommends that physicians and authorities consider the following Covid-19 treatment protocol for the early treatment of people at high risk or high exposure (see references below).
Note: Patients are asked to consult a doctor.
Zinc (50mg to 100mg per day)º
Hydroxychloroquine (400mg per day)*
Quercetin (500mg to 1000mg per day)º
Bromhexine (25mg to 75mg per day)º
Azithromycin (up to 500mg per day)*
Heparin (usual dosage)*
ion only (in most countries)
º) Also prophylactically (for high-risk persons)
Note: Quercetin may be used in addition to or as a replacement of hydroxychloroquine (HCQ). Contraindications for HCQ (e.g. favism or heart disease) and azithromycin must be observed. Treatment duration is five to seven days. Prophylactic treatment requires lower doses.
Addendum: Other drugs with first reported success in the early treatment of Covid-19 are ivermectin (read more) and favipiravir (read more).
Zinc/HCQ/AZ: US physicians reported an 84% decrease in hospitalization rates, a 50% decrease in mortality rates among already hospitalized patients (if treated early), and an improvement in the condition of patients within 8 to 12 hours. Italian doctors reported a decrease in deaths of 66%.
Bromhexine: Iranian doctors reported in a study with 78 patients a decrease in intensive care treatments of 82%, a decrease in intubations of 89%, and a decrease in deaths of 100%. Chinese doctors reported a 50% reduction in intubations.
For more results, see the scientific references below.
Mechanisms of action
Zinc inhibits RNA polymerase activity of coronaviruses and thus blocks virus replication. Hydroxychloroquine and quercetin support the cellular absorption of zinc and have additional anti-viral properties. Bromhexine inhibits the expression of the cellular TMPRSS2 protease and thus the entry of the virus into the cell. Azithromycin prevents bacterial superinfections. Heparin prevents infection-related thromboses and embolisms in patients at risk. (See scientific references below).
See also: Illustration of the mechanisms of action of HCQ, quercetin and bromhexine
The early treatment of patients as soon as the first typical symptoms appear and even without a PCR test is essential to prevent progression of the disease. Zinc, HCQ, quercetin and bromhexin may also be used prophylactically for people at high risk or high exposure (e.g. for health care workers).
In contrast, isolating infected high-risk patients at home and without early treatment until they develop serious respiratory problems, as often happened during lockdowns, may be detrimental.
The alleged or actual negative results with hydroxychloroquine in some studies were based on delayed use (intensive care patients), excessive doses (up to 2400mg per day), manipulated data sets (the Surgisphere scandal), or ignored contraindications (e.g., favism or heart disease).
Early treatment based on the above protocol is intended to avoid hospitalization. If hospitalization nevertheless becomes necessary, experienced ICU doctors recommend avoiding invasive ventilation (intubation) whenever possible and using oxygen therapy (HFNC) instead.
It is conceivable that the above treatment protocol, which is simple, safe and inexpensive, could render more complex medications, vaccinations, and other measures largely obsolete.............................."